<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Bethesda 2014 classification system for cervical cytology</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Bethesda 2014 classification system for cervical cytology</h1>
<div class="graphic"><div class="figure"><div class="ttl">Bethesda 2014 classification system for cervical cytology</div><div class="cntnt"><table cellspacing="0"><tbody> <tr> <td class="subtitle1_single">Specimen type</td> </tr> <tr class="divider_bottom"> <td class="indent1">Indicate conventional smear (Pap smear), liquid-based preparation (Pap test), versus other</td> </tr> <tr> <td class="subtitle1_single">Specimen adequacy</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Satisfactory for evaluation (describe presence or absence of endocervical/transformation zone component and any other quality indicators, eg, partially obscuring blood, inflammation, etc) </li> <li>Unsatisfactory for evaluation (<em>specify reason</em>) <ul> <li>Specimen rejected/not processed (<em>specify reason</em>) </li> <li>Specimen processed and examined, but unsatisfactory for evaluation of epithelial abnormality because of (<em>specify reason</em>) </li> </ul> </li> </ul> </td> </tr> <tr> <td class="subtitle1_single">General categorization (<em>optional</em>)</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Negative for intraepithelial lesion or malignancy </li> <li>Other: see "Interpretation/results" (eg, endometrial cells in a woman older than 45 years) </li> <li>Epithelial cell abnormality: see "Interpretation/results" (specify "squamous" <em>or</em> "glandular," as <em>appropriate</em>) </li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Interpretation/results</td> </tr> <tr> <td class="indent1"><strong>Negative for intraepithelial lesion or malignancy</strong></td> </tr> <tr> <td class="indent2">(When there is no cellular evidence of neoplasia, state this in the "General categorization" above and/or in the "Interpretation/results" section of the report—whether there are organisms or other non-neoplastic findings)</td> </tr> <tr> <td class="indent1"><strong>Non-neoplastic findings (<em>optional to report</em>)</strong></td> </tr> <tr> <td class="indent2"> <ul> <li><strong>Non-neoplastic cellular variations:</strong> <ul> <li>Squamous metaplasia </li> <li>Keratotic changes </li> <li>Tubal metaplasia </li> <li>Atrophy </li> <li>Pregnancy-associated changes </li> </ul> </li> <li><strong>Reactive cellular changes associated with:</strong> <ul> <li>Inflammation (includes typical repair) <ul> <li>Lymphocytic (follicular) cervicitis </li> </ul> </li> <li>Radiation </li> <li>Intrauterine contraceptive device (IUD) </li> </ul> </li> <li><strong>Glandular cells status posthysterectomy</strong> </li> </ul> </td> </tr> <tr> <td class="indent1"><strong>Organisms</strong></td> </tr> <tr> <td class="indent2"> <ul> <li><em>Trichomonas vaginalis</em> </li> <li>Fungal organisms morphologically consistent with <em>Candida</em> spp </li> <li>Shift in flora suggestive of bacterial vaginosis </li> <li>Bacteria morphologically consistent with <em>Actinomyces</em> spp</li> <li>Cellular changes consistent with herpes simplex virus </li> <li>Cellular changes consistent with cytomegalovirus </li> </ul> </td> </tr> <tr> <td class="indent1"><strong>Other</strong></td> </tr> <tr> <td class="indent2"> <ul> <li>Endometrial cells (in a woman older than 45 years)<br/> (also specify if "negative for squamous intraepithelial lesion") </li> </ul> </td> </tr> <tr> <td class="indent1"><strong>Epithelial cell abnormalities</strong></td> </tr> <tr class="divider_bottom"> <td class="indent2"> <ul> <li><strong>Squamous cell</strong> <ul> <li>Atypical squamous cells <ul> <li>Of undetermined significance (ASC-US) </li> <li>Cannot exclude HSIL (ASC-H) </li> </ul> </li> <li>Low-grade squamous intraepithelial lesion (LSIL)<br/> (encompassing: HPV/mild dysplasia/CIN-1) </li> <li>High-grade squamous intraepithelial lesion (HSIL)<br/> (encompassing: moderate and severe dysplasia, CIS; CIN-2 and CIN-3) <ul> <li>With features suspicious for invasion (<em>if invasion is suspected</em>) </li> </ul> </li> <li>Squamous cell carcinoma </li> </ul> </li> <li><strong>Glandular cell</strong> <ul> <li>Atypical <ul> <li>Endocervical cells (NOS <em>or specify in comments</em>) </li> <li>Endometrial cells (NOS <em>or specify in comments</em>) </li> <li>Glandular cells (NOS <em>or specify in comments</em>) </li> </ul> </li> <li>Atypical <ul> <li>Endocervical cells, favor neoplastic </li> <li>Glandular cells, favor neoplastic </li> </ul> </li> <li>Endocervical adenocarcinoma in situ </li> <li>Adenocarcinoma <ul> <li>Endocervical </li> <li>Endometrial </li> <li>Extrauterine </li> <li>Not otherwise specified (NOS) </li> </ul> </li> </ul> </li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Other malignant neoplasms (<em>specify</em>)</td> </tr> <tr> <td class="subtitle1_single">Adjunctive testing</td> </tr> <tr class="divider_bottom"> <td class="indent1">Provide a brief description of the test method(s) and report the result so that it is easily understood by the clinician</td> </tr> <tr> <td class="subtitle1_single">Computer-assisted interpretation of cervical cytology</td> </tr> <tr class="divider_bottom"> <td class="indent1">If case examined by an automated device, specify the device and result</td> </tr> <tr> <td class="subtitle1_single">Educational notes and comments appended to cytology reports (<em>optional</em>)</td> </tr> <tr> <td class="indent1">Suggestions should be concise and consistent with clinical follow-up guidelines published by professional organizations (references to relevant publications may be included)</td> </tr> </tbody></table></div><div class="graphic_footnotes">Pap: Papanicolaou; HPV: human papillomavirus; CIN: cervical intraepithelial neoplasia; CIS: carcinoma in situ.</div><div class="graphic_reference">From: Nayar R, Wilbur DC. The Pap Test and Bethesda 2014: "The reports of my demise have been greatly exaggerated. (after a quotation from Mark Twain)". J Low Genit Tract Dis 2015; 19:175. DOI: <a href="http://journals.lww.com/jlgtd/Abstract/2015/07000/The_Pap_Test_and_Bethesda_2014___The_reports_of_my.1.aspx" target="_blank">10.1097/LGT.0000000000000115</a>. Copyright © 2015 American Society for Colposcopy and Cervical Pathology, The International Society for the Study of Vulvovaginal Disease, and The International Federation of Cervical Pathology and Colposcopy. Reproduced with permission from Lippincott Williams &amp; Wilkins. Unauthorized reproduction of this material is prohibited.</div><div id="graphicVersion">Graphic 102346 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
